Embleema

Embleema is a crypto & web3 company in New York, United States, founded in 2019. It has raised $4.1M across 2 rounds, most recently a $3.7M Series A in February 2019.

Long-term studies made simple and scalable

Headquarters
New York, New York
Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$4.1M
Last Round
$3.7M Series AFeb 2019
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.

About

Embleema is a real-world evidence (RWE) platform that enables life sciences companies to run registries, Phase IV trials, and non-interventional studies using multimodal patient data including ePRO, wearables, EHR, and site data. The platform captures audit-ready data from day one, connecting 60,000+ care centers and reducing study costs by 40% versus traditional CROs. Patients can track symptoms and consent to matched research studies.

Summary

It lists 11–50 employees. It has raised $4.1M in total across 2 rounds, most recently a $3.7M Series A round in Feb 2019. Investors include Pharmagest, MassChallenge and Techstars.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Series ASeries AFeb 2019
$3.7M

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

BullishIPO

Regulated institutional-grade cryptocurrency exchange offering spot trading for Bitcoin, Ethereum...

George Town, Cayman Islands201–500Fintech, Crypto & Web3
Corporate RoundTotal funding$10.0BMay 2021
MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
IREN LimitedIPO

IREN provides vertically integrated AI cloud services, delivering large-scale data centers and GP...

Perth, Australia201–500Cloud, Crypto & Web3
ConvertibleTotal funding$5.6BMay 2026
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Embleema on Indexed.vc
<a href="https://indexed.vc/companies/embleema"><img src="https://indexed.vc/api/badge/company/embleema" alt="Embleema on Indexed.vc" width="260" height="76" /></a>